Methods and compositions for interference with DNA polymerase and DNA synthesis
Disclosed are methods and compositions for inhibiting DNA synthesis in a cell using RNA. Inhibition of DNA synthesis by RNA can be used, for example, in analytical methods, as a research tool to affect cells under study, to synchronize cell cycle in a cell culture, and to inhibit cell growth. For example, inhibition of DNA synthesis in cancer cells can be used to inhibit cancer cells and treat cancer. The RNA can be any RNA, such as whole cell RNA, whole cell mRNA, whole cell ribosomal RNA, whole cell transfer RNA, synthetic RNA, recombinant RNA, modified RNA, or a combination. The composition can comprise RNA and a pharmaceutically acceptable carrier or RNA, a targeting molecule, and a pharmaceutically acceptable carrier. The targeting molecule can be a tumor-targeting peptide.
1. A method of inhibiting DNA synthesis in a cell, the method comprising bringing into contact RNA and the cell such that the RNA enters the cell and binds to DNA polymerase in the cell such that DNA synthesis in the cell is inhibited, wherein the RNA has a sequence complexity of 1X10 4 or more.
2. The method of claim 1 , wherein the cell is a cell in a subject.
3. The method of claim 2 , wherein the cell is a cancer cell, wherein inhibition of DNA synthesis in the cell kills the cancer cell, or inhibits replication or growth of the cancer cell.
4. The method of claim 2 , wherein the RNA is administered to the subject.
5. The method of claim 1 , wherein the RNA is modified RNA.
6. The method of claim 1 , wherein the RNA is comprised in a composition, wherein the composition further comprises a pharmaceutically acceptable carrier.
7. The method of claim 6 , wherein the composition further comprises a targeting molecule, wherein the RNA is brought into contact with the cell by targeting the RNA to the cell via the targeting molecule.
8. The method of claim 7 , wherein the targeting molecule is a tumor-targeting peptide selected from the group consisting of RGD, CAR, LyP-1, NGR, and RGR.
9. The method of claim 1 , wherein the RNA consists essentially of sequences homologous to cellular RNAs inside the cell.
10. The method of claim 1 , wherein the RNA does not include a substantial open reading frame, does not include functional translation control sequences or elements, or a combination thereof, whereby the RNA does not functionally encode a protein.
11. The method of claim 1 , wherein inhibition of DNA synthesis in the cell inhibits growth of the cell.
12. The method of claim 1 , wherein inhibition of DNA synthesis in the cell inhibits replication of the cell.
13. The method of claim 1 , wherein inhibition of DNA synthesis in the cell kills the cell.